🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Great ? about PCI outcome in diabetics and low SYNTAX score. We will have to look. There may not be that many! #CardsJC

A key question that needs to be answered about higher event rates in FFR-deferred ACS patients c/w FFR-deferred stable pts is whether the events are due to the FFR-deferred lesion or the ACS substrate. #CardsJC

Thanks for the invitation!! #CardsJC

#EAPCI Quality of Life After FFR-Guided PCI Compared w/ CABG ahajournals.org/doi/pdf/10.116… PCRonline 🫀 European Society of Cardiology European Society of Cardiology Journals #ACC22

#OriginalResearch SimPub #ACC22: New data from #FAME3 RCT: In 3-vessel CAD, FFR-guided #PCI and #CABG yielded similar #QoL after 12mo, but earlier improvements with #PCI William Fearon #AHAJournals ahajrnls.org/3NUtsE8

Post-PCI FFR in FAME 3. What do the numbers tell us? A LBCT @CRF #TCT2022 and published simultaneously in Circulation: Cardiovascular Interventions: ahajournals.org/doi/10.1161/CI… Piroth Zsolt Danielle Keulards William Fearon #AHAJournals #ACCFIT #TCTConference #Cardiotwitter

Congrats Jung-Min Ahn on publishing these data in CircInterventions evaluating cross-talk from serial lesions with NHPRs and FFR. doi.org/10.1161/CIRCIN…

The Impact of Serial Coronary Stenoses on Various Coronary Physiology Indices. ahajournals.org/doi/10.1161/CI… William Fearon #AHAJournals

It is always hard to enroll all comers in studies like this where the treatment strategies are so different. Slow enrolment with few patients per month from each center suggests that this was a select population. Need to take this into account when analyzing the results. #CardsJC

Also more angina in STITCH. The low rate of significant angina in REVIVED is important to note. Those patients with significant angina are the ones who are most likely to benefit from PCI with respect to quality of life. #CardsJC

Although viability was demonstrated, one wonders if all lesions treated were responsible for ischemia. Ischemia-producing lesions are the ones most likely to benefit from PCI. #CardsJC

Most of us have seen patients with low EF and CAD who have benefitted from PCI. The key is how to best identify these patients. REVIVED gives us pause in treating all patients. We need to get better at identifying those who are most likely to benefit. #CardsJC

#TeamScience meeting discussion at CV Medicine Division Stanford Department of Medicine 2 facilitate greater collaborations among faculty within division/department & outside.Robert Harrington Kenneth Mahaffey Joseph C Wu, MD, PhD Eldrin Lewis Josh Knowles euan ashley Dr. Michael Salerno M.D. P.h.D Paul Cheng Han Zhu William Fearon

In an era of increasing aortic valve-in-valve procedures what have we learned? A call for papers for our special themed issue “Redo Aortic Valve Interventions”. Deadline May 15, 2023. #TAVR #SAVR #Cardiotwitter #AHAJournals ahajournals.org/journal/circin…

Interventional Cards Twitter—need your help to assess current global trends in invasive coronary physiology use. Please take 2 min to fill out this quick survey! William Fearon Emmanouil Brilakis David J. Cohen, MD, MSc Eric Secemsky MD MSc Nadia Sutton Yohan Chacko Jonathan Schwartz, MD surveymonkey.com/r/CK88KQ3

#SimPub #CircTCT24 #Editorial What can coronary physiological testing teach us about which patients may derive anginal benefit from #PCI? William Fearon ahajrnls.org/4hpDvQT

How does the presence of a CTO effect outcomes in FFR guided therapy for 3-vessel CAD? A comparison of PCI versus CABG. A FAME-3 Substudy Hisao Otsuki Tatsunori Takahashi, MD William Fearon #cardiotwitter #AHAJournals ahajrnls.org/3CEIInY

How does a bifurcation lesion influence your revascularization strategy? Impact of bifurcation lesions on outcomes after FFR-guided PCI or CABG. Results from the FAME-3 Trial #cardiotwitter #CardioX #AHAJournals @bernardbruyne William Fearon Piroth Zsolt ahajrnls.org/4h6YZkD

In the FAME 3 trial, at 3 years, women had similar outcomes with #FFR-guided #PCI compared with #CABG, whereas men had improved outcomes with CABG. jacc.org/doi/10.1016/j.… #JACCINT #cvCABG #cvCAD William Fearon

📢 Inviting all interventional cardiologists to complete a survey on the utilization of coronary physiology. Help our understanding of current practices, including usage frequency, preferred modalities, and optimal timing. 🔗Complete the survey now: redcap.link/physiologysurv…